https://www.selleckchem.com/products/k-975.html
3% versus 37.8%) and shorter median hospital stays (11 days versus 13 days) than did AGC-open patients (all p 0.05). The 3-year recurrence-free and overall survival was 66.2% and 88.8% in the AGC-lap group and 51% and 66.3% in the AGC-open group (both p = 0.1). The perioperative features, including operative time, number of lymph nodes harvested, hospital stay, and complication rates, were similar between the AGC- and EGC-lap groups. LDG was safely and effectively performed in elderly AGC patients, resulting in faster recovery and a
Like
Comment
Share
